Cargando…
Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?
Mesenchymal stromal cells (MSC) have immune regulatory and tissue regenerative properties. MSCs are being studied as a therapy option for many inflammatory and immune disorders and are approved to treat acute graft-versus-host disease (GvHD). The severe acute respiratory syndrome coronavirus-2 (SARS...
Autores principales: | Hamdan, Hamdan, Hashmi, Shahrukh K., Lazarus, Hillard, Gale, Robert Peter, Qu, Wenchun, El Fakih, Riad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425550/ https://www.ncbi.nlm.nih.gov/pubmed/32854985 http://dx.doi.org/10.1016/j.blre.2020.100742 |
Ejemplares similares
-
Hitting the Holy Grail of Hematopoietic Cell Transplantation with Naive T-Cell Depleted Allografts—Graft Engineered Hematopoietic Stem Cell Transplant
por: El Fakih, Riad, et al.
Publicado: (2017) -
Clinical, Diagnostic and Prognostic Characteristics of Primary Cutaneous Gamma Delta T-cell Lymphomas
por: Muhsen, Ibrahim N., et al.
Publicado: (2022) -
Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges
por: Wang, Shihua H., et al.
Publicado: (2021) -
Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Severe COVID-19
por: Xiong, Jing, et al.
Publicado: (2021) -
Liaisons Dangereuses? new drugs, physicians and the drug industry
por: Gale, Robert Peter, et al.
Publicado: (2020)